These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32883464)
21. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors. Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995 [TBL] [Abstract][Full Text] [Related]
22. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us? Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375 [TBL] [Abstract][Full Text] [Related]
23. Cancer of the gastroesophageal junction: combined modality therapy. Ilson DH Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275 [TBL] [Abstract][Full Text] [Related]
24. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management? Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690 [TBL] [Abstract][Full Text] [Related]
25. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction]. Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536 [TBL] [Abstract][Full Text] [Related]
26. Cancer of the esophagogastric junction. Stein HJ; Feith M; Siewert JR Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305 [TBL] [Abstract][Full Text] [Related]
27. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer. Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F; Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186 [TBL] [Abstract][Full Text] [Related]
28. Staging of adenocarcinoma of the gastroesophageal junction. Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127 [TBL] [Abstract][Full Text] [Related]
29. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran. Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826 [TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Hasegawa S; Yoshikawa T Gastric Cancer; 2010 Jun; 13(2):63-73. PubMed ID: 20602191 [TBL] [Abstract][Full Text] [Related]
31. Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study. De Pasqual CA; van der Sluis PC; Weindelmayer J; Lagarde SM; Giacopuzzi S; De Manzoni G; Wijnhoven BPL Dis Esophagus; 2022 Aug; 35(8):. PubMed ID: 34969080 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of the esophago-gastric junction adenocarcinoma]. Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092 [TBL] [Abstract][Full Text] [Related]
34. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy. Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212 [No Abstract] [Full Text] [Related]
35. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option. Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865 [TBL] [Abstract][Full Text] [Related]
36. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647 [TBL] [Abstract][Full Text] [Related]
37. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755 [TBL] [Abstract][Full Text] [Related]
38. Controversies in the treatment of local and locally advanced gastric and esophageal cancers. Cohen DJ; Leichman L J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302 [TBL] [Abstract][Full Text] [Related]